According to the list of China Industrial Awards just announced, the Tianshili Group from Tianjin and the China Lunar Exploration Engineering Detector System and the Aircraft Carrier Engineering of Dalian Shipbuilding Industry Co., Ltd. won the China Industrial Award.
Lifting the traditional medicine intelligent manufacturing banner, Tianshili Chinese medicine "going out to sea" three steps
Towards overseas markets, it represents the voice of Chinese manufacturing. For Chinese medicine companies, no matter which step, they test the judgment and execution of enterprises, and they need to "prescribe the right medicine."
When the transformation and upgrading of the manufacturing industry has gradually become the new focus of China's economic development, the pharmaceutical industry can raise the banner of traditional medical intelligent manufacturing to become the focus of attention. The acquisition of the China Industrial Awards has enabled Tianshili to develop its strength in the field of intelligent manufacturing for many years. Show it.
Tasly Voice of the Industrial Awards
Who can represent the highest level of manufacturing in China? Looking across the side of the mountain into a peak, you can give different answers from different angles. The promulgation of the China Industrial Awards has temporarily ended the debate. At least for now, the winners can say aloud that China is making me.
According to the list of China Industrial Awards just announced, the Tianshili Group from Tianjin and the China Lunar Exploration Engineering Detector System and the Aircraft Carrier Engineering of Dalian Shipbuilding Industry Co., Ltd. won the China Industrial Award.
In the Chinese manufacturing sector, the authority and high-end of the China Industrial Awards are unmatched. The award was established by the State Council and is selected once every two years. It is known as the "Oscar" of Chinese industry. Representing China's highest-impact space exploration, aircraft carrier manufacturing and high-speed rail system, and sharing this award with Tasly.
In the field of Chinese medicine, the most influential event in recent years is obviously that Tu Yu won the Nobel Prize. “Artemisinin†promoted the innovation of traditional Chinese medicine to the world’s science and technology honor hall, and further stimulated the interest of Chinese medicine at home and abroad. With enthusiasm, it has placed more concern and expectation on Chinese medicine, and has set off a wave of “Nuggets†Chinese medicine at home and abroad. Tasly won the Industrial Award, and it proved from the industrialization field that the combination of traditional Chinese medicine and intelligent manufacturing has a promising future.
In fact, industrialization and intelligence are also important targets for Tasly to come today. Since its establishment in 1994, it has grown into a high-tech health industry group with the biomedical industry as its core and the health care industry and health service industry as its two wings. In 2015, Tasly sold over 41.3 billion yuan of assets and sales of 282. A transcript of 100 million yuan and profits and taxes of 3.1 billion yuan. Industry experts believe that with the support of a strong innovation system, Tasly has become a benchmark enterprise that leads the innovation of China's traditional Chinese medicine industry and has won the core competitiveness of the China Industrial Award.
In April 2015, Tasly successfully passed the on-site identification and publicity of the digital innovation and production capacity of the modern Chinese medicine manufacturing industry. It became the first enterprise in the country, the first in Tianjin, and the first in Tianjin pharmaceutical industry. It is recommended to become one of the 20 demonstration enterprises in the country.
In addition to enterprises, the Ministry of Industry and Information Technology recently issued the "Intelligent Manufacturing Development Plan (2016-2020)" clearly stated that the new generation of information and communication technologies and manufacturing industries represented by the Internet are accelerating integration, and intelligent manufacturing is increasingly becoming a major development in the manufacturing industry. Trends and core content.
Three steps of Chinese medicine going to sea
For Chinese people, the most direct impression of Chinese medicine going out is that a Chinese medicine clinic has been opened in a certain overseas place, or acupuncture technology has cured the pain of a famous person. In addition to the joy, the Chinese medicine industry is slightly embarrassed that these achievements are more of the past achievements of Chinese medicine, relying on the individual ability of practitioners, it is difficult to enhance the status of Chinese medicine overseas from the industry as a whole. The creation of contemporary Chinese medicine glory, more needs is the modern industrial technology upgrade.
Taking Tasly as an example, since the state advocated and promoted the strategic action of Chinese medicine internationalization, it has gone through 20 years of history. Since 1996, Tasly has responded positively to the strategic deployment of the state to promote and promote the modernization of traditional Chinese medicine. Modern Chinese medicine compound Danshen Dropping pills opened the declaration to the US FDA (US Food and Drug Administration), and experienced a difficult journey from exploration, persistence to accumulation, innovation to steady progress, and achieved a major breakthrough in the internationalization of Chinese medicine, and also led to the modern Chinese medicine achieved a Series of innovations and development achievements.
In 2015, the sales volume of Fufang Danshen Drop Pills reached 3.3 billion yuan, winning the top of the annual sales volume of Chinese proprietary Chinese medicines for 13 consecutive years.
Out of the overseas market, it represents the voice of Chinese manufacturing. For Chinese medicine companies, no matter which step, it will test the judgment and execution of the company, and it is necessary to "prescribe the right medicine." In Tasly, the internationalization of Chinese medicine takes a "three-step" strategy. The first step of "going out" is to go abroad and reflect the innovative spirit of Chinese medicine products and Chinese medicine enterprises. The second step of "going in" is to realize the international docking of Chinese medicine technology and standards, and to achieve technological upgrading. Make Chinese medicine truly become an "international drug"; the third step, "go up", embark on the high-end market and become a clinical first-line drug that can be accepted and used by foreign doctors, patients and medical insurance institutions. Through these three steps, Chinese medicine can achieve registration through international drug administration, technical standards are in line, language and culture are barrier-free, products have affinity, and consumers have a sense of trust.
It is difficult to know how easy it is to do. The internationalization of Chinese medicine of Tasly shows to some extent the difficulty of Chinese medicine going to sea. Take the world's first Chinese medicine compound preparation Danshen Dripping Pill, which is the first in the world to complete the FDA Phase III clinical trial. From 1996, Compound Danshen Dripping Pills was selected as the first compound Chinese patent medicine to be filed with the US FDA. By 2009, Phase II clinical trials were successfully completed. Through more than 10 years of hard work, Tasly has achieved a historic breakthrough in the internationalization of Chinese medicine: 2010 In July, the US FDA fully approved the results of the compound Danshen Dripping Pill and agreed to enter the Phase III clinical trial. In March 2016, Hyundai Chinese Medicine Compound Danshen Dropping Pill successfully completed the US FDA Phase III clinical trial in more than 120 clinical centers in 9 countries and regions around the world, entering the data statistics and preparation of new drug declarations. This is the world's first Chinese medicine compound preparation to complete the FDA phase III clinical trial, which is a milestone for the internationalization of Chinese medicine.
In October 2016, the state issued the “Healthy China 2030 Planning Outlineâ€, clearly stating that it is necessary to give full play to the unique advantages of traditional Chinese medicine, accelerate the creation of multinational companies and internationally renowned Chinese brands in the entire industrial chain, and promote the development of Chinese medicine to the world. For Tasly, on the road of opportunities and challenges, how to make your own voice has a long way to go.
Optical Prism,Dispersion Prism,Si Right Angle Prism,Chandelier Prisms
Danyang Horse Optical Co., Ltd , https://www.dyhorseoptical.com